Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Total replacement of hip joint is one of the most important medical innovations of the twentieth century. More than 100,000 hip replacements are being laid each year in France.
Improved fixation, reduced wear rates and reduced implant dislocation rates remain subjects of continuous improvement.
Hip implants cemented and cementless are part of therapeutic arsenal of orthopedic surgeons for joint replacement of the defective hip.
The anchor and friction torque are both essential to the survival of hip implants. Therefore acetabular implants without cement with ceramic insert or polyethylene in a metalback or full polyethylene coated with titanium grains without metalback are proposed, but they have their own complications (Squeaking, fractures, recovery difficulties, difficult radiographic analysis, high cost for ceramics, primary stability defects, instability of the instrument set, Titanium residues in absence of metalback. An alternative to these implants may be an acetabular component without cement with polyethylene insert with an end metalback to increase both polyethylene thickness and size of the head in order to expect a low complication rate with important longevity for a lower cost.
This study was conducted to ensure the safety and effectiveness of the acetabular implant "POLYMAX"
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with acetabular implant | Data to be collected are :
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Early complications data | Other | Early complications of interest are :
|
| Measure | Description | Time Frame |
|---|---|---|
| Innocuity of POLYMAX acetabular implant as assessed by data collected on early complications | 60 months | |
| Innocuity of POLYMAX acetabular implant as assessed by data collected on late-stage complications | 60 months |
| Measure | Description | Time Frame |
|---|---|---|
| Efficacity of POLYMAX acetabular implant as assessed by Harris clinical score | 60 months | |
| Patient satisfaction as assessed by Womac reduced score | 60 months | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patient with osteoarthritis
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Philippe CHIRON, MD | University Hospital of Toulouse | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Saint Grégoire Hospital | Saint-Grégoire | 56816 | France | |||
| Purpan Hospital |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Late stage complications data | Other | Late complications taken into account are:
|
|
| Patient Satisfaction | Other | Patient satisfaction evaluated by Womac reduced Score |
|
| Efficacity | Other | Efficacity as evaluated by Harris HIP score |
|
| Radiographic evaluation | Other | Bone reaction visible in radiography |
|
| Evaluation of implant good holding as assessed by apparition of radiolucent lines in radiography |
| 60 months |
| Toulouse |
| 31059 |
| France |
| ID | Term |
|---|---|
| D010003 | Osteoarthritis |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
Not provided
Not provided